ST Pharm Co.Ltd (237690) — Capital Reinvestment Ratio
Latest as of September 2025:
0.50x
ST Pharm Co.Ltd (237690) has a Capital Reinvestment Ratio of 0.50x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩29.25 Billion) in capital expenditures (₩14.61 Billion). See ST Pharm Co.Ltd free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.50x
Capex / Operating Cash Flow
Operating Cash Flow
₩29.25 Billion
KRW
Capital Expenditures
₩14.61 Billion
KRW
Data as of
Sep 2025
Most recent filing
ST Pharm Co.Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks ST Pharm Co.Ltd's Capital Reinvestment Ratio across 9 annual periods.
Annual Capital Reinvestment Ratio for ST Pharm Co.Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for ST Pharm Co.Ltd from 2015 to 2025. For live market cap and broader valuation context, see ST Pharm Co.Ltd stock valuation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 3.38x | ₩13.99 Billion | ₩47.29 Billion | ▲ +344.5% |
| 2024 | 0.76x | ₩109.45 Billion | ₩83.22 Billion | ▼ -97.7% |
| 2023 | 33.46x | ₩1.30 Billion | ₩43.44 Billion | ▲ +287.8% |
| 2022 | 8.63x | ₩7.03 Billion | ₩60.66 Billion | ▲ +21.1% |
| 2021 | 7.12x | ₩7.27 Billion | ₩51.79 Billion | ▲ +182.4% |
| 2018 | 2.52x | ₩10.77 Billion | ₩27.17 Billion | ▲ +395.9% |
| 2017 | 0.51x | ₩54.44 Billion | ₩27.70 Billion | ▲ +61.1% |
| 2016 | 0.32x | ₩50.78 Billion | ₩16.03 Billion | ▼ -49.5% |
| 2015 | 0.63x | ₩35.82 Billion | ₩22.40 Billion | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow